The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) was terminated in April. After sweeping cuts ...

Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...

US President Donald Trump has resurrected a drug pricing plan that equates to International Reference Pricing.

The US Food and Drug Administration has granted approval to Amneal Pharmaceuticals’ Brekiya (dihydroergotamine (DHE) mesylate ...

The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.